NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/20/2025
Back to search
Official data from USPTO
BLIXFULI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
05/20/2025
Trademark type
Word
Nice classes
5
Filing date
04/08/2024
Registration date
05/20/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/20/2025
Last transaction
05/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Carrigtohill, Co. Cork, IE
Examiner
LINDEMANN, ROBIN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
G. U. (pessoa física)
Representatives
Jack Wessel Gilead Sciences, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis; pharmaceutical preparations for treatment of gastrointestinal diseases and disorders
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/20/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/01/2025
PUBO
PUBLISHED FOR OPPOSITION
04/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/26/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/30/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/28/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/27/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/27/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/27/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/25/2024
GNRT
NON-FINAL ACTION E-MAILED
10/25/2024
CNRT
NON-FINAL ACTION WRITTEN
10/25/2024
DOCK
ASSIGNED TO EXAMINER
10/21/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2024
NWAP
NEW APPLICATION ENTERED
04/08/2024
Continuous trademark protection
Get notified about every new filing that threatens BLIXFULI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.